Back to Journals » Therapeutics and Clinical Risk Management » Volume 16

Original Research

Comparative Treatment Patterns and Outcomes of Fulvestrant versus Everolimus Plus Exemestane for Postmenopausal Metastatic Breast Cancer Resistant to Aromatase Inhibitors in Real-World Experience

       
Total article views   HTML views PDF downloads Totals
6,863 Dovepress* 6,256+ 1,020 7,276
PubMed Central* 607 165 772
Totals 6,863 1,185 8,048
*Since 30 June 2020
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 0 2

View citations on PubMed Central and Google Scholar